Track topics on Twitter Track topics that are important to you
A new test identifies men with castration-resistant prostate cancer who have a poorer response to abiraterone and enzalutamide.
Medscape Medical News
Original Article: New Biomarker Signals Poor Response in Prostate CancerNEXT ARTICLE
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...